Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
renal denervation
MedTech
Cardiac tech pushes Medtronic's Q2 earnings past expectations
The medtech giant’s CEO, Geoff Martha, described the moment as a pivotal inflection point for the company.
Conor Hale
Nov 18, 2025 11:15am
New blood pressure guidelines include renal denervation
Aug 18, 2025 3:15pm
Medtronic treats first patient in multi-organ denervation study
Jul 9, 2025 11:45am
Boston Scientific snags renal denervation developer SoniVie
Mar 3, 2025 11:15am
CMS to pay for renal denervation from Medtronic, Recor Medical
Nov 6, 2024 4:45am
Medtronic claims long-sought FDA approval in renal denervation
Nov 20, 2023 10:21am
